Enlivex Therapeutics Adopts RAIN Token Strategy with $212M Investment
- Enlivex Therapeutics plans to use $212 million from a private placement to integrate the RAIN token into its treasury strategy.
- The RAIN token, linked to an Arbitrum-based prediction market platform, doubled in value from $0.0038 to $0.0076 after the announcement.
- As of the latest update, RAIN was trading at $0.007, marking a near 100% increase within 24 hours.
- Former Italian Prime Minister Matteo Renzi has been appointed to Enlivex’s board of directors.
- The funds will also support the continued development of Allocetra, a therapy for osteoarthritis.
Trading Analysis
Trading Signal: BULLISH (Score: +7)
The announcement significantly increased RAIN’s value and institutional interest in prediction markets is growing.
Price Levels:
Current: $0.007
Support: Not specified | Resistance: Not specified
24h/Recent Range: $0.0038 – $0.0076
Catalysts & Timeline:
• Near-term: Completion of transaction expected by November 25, 2025
The integration of RAIN token by Enlivex Therapeutics has led to a significant price surge, reflecting strong market interest and potential growth in decentralized prediction markets.
Source (3.2)https://cryptobriefing.com/rain-pumps-100-prediction-markets-treasury-enlivex-funding/?rand=59535
